本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Elanco Animal Health Inc

18.35
-0.1000-0.54%
成交量:7,126.88万
成交额:13.08亿
市值:91.17亿
市盈率:20.97
高:18.57
开:18.37
低:18.16
收:18.45
52周最高:18.87
52周最低:8.02
股本:4.97亿
流通股本:4.93亿
量比:7.34
换手率:14.46%
股息:- -
股息率:- -
每股收益(TTM):0.8753
每股收益(LYR):0.6842
净资产收益率:6.83%
总资产收益率:0.98%
市净率:1.35
市盈率(LYR):26.82

数据加载中...

公司资料

公司名字:
Elanco Animal Health Inc
交易所:
NYSE
成立时间:
1954
员工人数:
9225
公司地址:
2500 Innovation Way,Greenfield,Indiana,United States
邮编:
46140
电话:
传真:
- -
简介:
Elanco Animal Health Incorporated于2018年5月3日在印第安纳州注册成立。Elanco成立于1954年,是Eli Lilly and Company的一部分,是一家首屈一指的动物保健公司,致力于为兽医和动物食品的创新,开发,生产和销售产品。公司总部位于印第安纳州格林菲尔德,是世界第四大动物保健公司。该公司还拥有同伴动物领域最广泛的宠物寄生虫产品组合之一。Elanco Animal Health提供超过125个品牌的多元化产品组合,使其成为90多个国家兽医和动物食品生产商值得信赖的合作伙伴。

董事

名称
职位
Jeffrey N. Simmons
President, Chief Executive Officer and Director
Lawrence E. Kurzius
Chairman of the Board
Art A. Garcia
Independent Director
Deborah T. Kochevar
Independent Director
Denise Scots Knight
Independent Director
Kapila K. Anand
Independent Director
Kirk P. McDonald
Independent Director
Michael J. Harrington
Independent Director
Paul S. Herendeen
Independent Director
R. David Hoover
Independent Director
Stacey Ma
Independent Director

股东

名称
职位
Jeffrey N. Simmons
President, Chief Executive Officer and Director
James M. Meer
Senior Vice President and Chief Accounting Officer
Robert M. VanHimbergen
Executive Vice President and Chief Financial Officer
David S. Kinard
Executive Vice President, Human Resources, Corporate Communications and Administration
Ellen de Brabander
Executive Vice President, Innovation and Regulatory Affairs
Grace McArdle
Executive Vice President, Manufacturing and Quality
Jose Manuel Correia de Simas
Executive Vice President, U.S. Farm Animal Business
Rajeev A. Modi
Executive Vice President, U.S. Pet Health and Global Digital Transformation
Ramiro M. Cabral
Executive Vice President and President of Elanco International
Shiv O'Neill
Executive Vice President, General Counsel and Corporate Secretary
Timothy J. Bettington
Executive Vice President, Corporate Strategy and Market Development